Nuritas' AI-Discovered Peptides Are Now in Frozen Yogurt — and 31 Countries
BiohackingThe conversation around peptides in the longevity and performance space has centered on injectable protocols and clinical research. Nuritas is running a different play: using AI to discover peptides that survive food processing, then putting them in frozen yogurt.
What Happened
At IFT FIRST 2026, the international food science conference in Chicago, Nuritas showcased how its plant-based peptide hydrolysates are now available across four mainstream food application formats: frozen yogurt with muscle-health support, ready-to-drink and ready-to-mix beverages, savory functional snacks (including crisps and puffs), and bakery products.
The ingredient at the center of the display is PeptiStrong, Nuritas’ AI-discovered peptide ingredient targeting muscle health. According to the company, PeptiStrong ingredients have been validated for heat stability in both retort and UHT beverage processing across pH ranges — meaning they survive the commercial food manufacturing conditions that would denature most bioactive compounds.
The commercial footprint is already substantial. Nuritas reports its ingredients are commercially available in more than 31 countries and hold FDA GRAS status alongside Non-Novel designations in Canada and the EU. The company states it has supported more than 100 product launches to date.
Why It Matters
The regulatory designations matter because they signal where on the commercialization curve Nuritas actually sits. FDA GRAS status means the ingredients have been assessed as safe for general food use — a bar that filtered research compounds and early-stage ingredients can’t clear. The Non-Novel designations in Canada and the EU extend that clearance to major international markets.
What Nuritas does differently from pharmaceutical peptide development is the discovery method. The company’s proprietary Magnifier AI platform identifies peptide candidates from plant protein sources, which are then validated through clinical research. The output is an ingredient that has a computational origin story rather than a fermentation or synthesis route — the AI identifies which peptide sequences in plant proteins have functional properties before any wet lab work begins.
For the functional food and sports nutrition industry, the significance is scale. Peptide-enriched products have historically been limited to powders and capsules because the active compounds were fragile. An ingredient that survives frozen yogurt processing and UHT beverage manufacturing can reach consumer formats where supplement compliance is not required. You don’t have to remember to take it.
The trajectory connects directly to what Peter Attia’s research on peptide pharmacology describes as the growing legitimacy of peptide-based interventions — but Nuritas is pursuing food-matrix delivery rather than therapeutic applications.
The So What
AI-discovered functional peptides in commercial food formats represent a meaningful shift in how performance and longevity ingredients reach consumers. The Nuritas model — AI identifies the candidate, clinical research validates it, food manufacturing validates the stability, regulatory bodies clear it — is a more rigorous pipeline than most functional food ingredients clear. For anyone tracking where evidence-based performance nutrition is headed, PeptiStrong at IFT FIRST is a signal that AI-designed ingredients are moving from clinical research to grocery shelves.
Source: Longevity Technology
Content created with AI assistance and reviewed for accuracy.
Join the conversation
Stack Insiders is our free community for readers who want to go deeper — share resources, ask questions, and connect with others across every vertical we cover.
Join Stack Insiders →